pharma-company /Medicinal products /Active ingredients

Rx · PZN 09175103, 18036777, 19462683, 19177511…

XOLAIR 75 mg solution for injection in a pre-filled syringe

German trade nameXOLAIR 75 mg Injektionslösung in einer Fertigspritze

Active ingredientOmalizumabPharmaceutical formSolution for infusion

Only sporadically available

2.5

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Cold chain 2–8 °C

Average purchase price (B2B)

~ €470

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is an approximation across all recorded pack sizes. We are happy to advise you on your terms for XOLAIR 75 mg solution for injection in a pre-filled syringe.

Review purchasing terms

XOLAIR 75 mg solution for injection in a pre-filled syringe contains the active ingredient Omalizumab and comes as Solution for infusion. 9 pack sizes of this product are recorded. Availability in German wholesale varied over the past 30 days depending on pack size: from index 0.0 to 2.5 out of 10. The best-available pack was only sporadically available. 8 of the 9 packs are currently marketed according to our records.


Pack sizes · 9 PZN

PZNIndex 7 dIndex 30 d Highest known purchase price
180367772.42.5~ €770
091751030.00.0~ €246
194626830.00.0~ €770
191775110.00.0~ €239
099436250.00.0~ €246
197438090.00.0~ €246
196262800.00.0~ €737
187563650.00.0~ €239
195334890.00.0~ €737

XOLAIR 75 mg solution for injection in a pre-filled syringe was only sporadically procurable in the past 30 days. We help you identify additional sources of supply and alternative products.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. The average purchase price was calculated across all 9 recorded PZNs.